These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 32125018)
1. CD163-positive macrophage infiltration predicts systemic involvement in sarcoidosis. Isohisa T; Asai J; Kanemaru M; Arita T; Tsutsumi M; Kaneko Y; Arakawa Y; Wada M; Konishi E; Katoh N J Cutan Pathol; 2020 Jul; 47(7):584-591. PubMed ID: 32125018 [TBL] [Abstract][Full Text] [Related]
2. Myocardial Immunocompetent Cells and Macrophage Phenotypes as Histopathological Surrogates for Diagnosis of Cardiac Sarcoidosis in Japanese. Honda Y; Nagai T; Ikeda Y; Sakakibara M; Asakawa N; Nagano N; Nakai M; Nishimura K; Sugano Y; Ohta-Ogo K; Asaumi Y; Aiba T; Kanzaki H; Kusano K; Noguchi T; Yasuda S; Tsutsui H; Ishibashi-Ueda H; Anzai T J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27856486 [TBL] [Abstract][Full Text] [Related]
3. Macrophage polarisation: an immunohistochemical approach for identifying M1 and M2 macrophages. Barros MH; Hauck F; Dreyer JH; Kempkes B; Niedobitek G PLoS One; 2013; 8(11):e80908. PubMed ID: 24260507 [TBL] [Abstract][Full Text] [Related]
4. Serum levels of soluble CD163 as a specific marker of macrophage/monocyte activity in sarcoidosis patients. Tanimura H; Mizuno K; Okamoto H Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jul; 32(2):99-105. PubMed ID: 26278688 [TBL] [Abstract][Full Text] [Related]
5. AM-3K, an anti-macrophage antibody, recognizes CD163, a molecule associated with an anti-inflammatory macrophage phenotype. Komohara Y; Hirahara J; Horikawa T; Kawamura K; Kiyota E; Sakashita N; Araki N; Takeya M J Histochem Cytochem; 2006 Jul; 54(7):763-71. PubMed ID: 16517975 [TBL] [Abstract][Full Text] [Related]
6. CD163+ M2c-like macrophages predominate in renal biopsies from patients with lupus nephritis. Olmes G; Büttner-Herold M; Ferrazzi F; Distel L; Amann K; Daniel C Arthritis Res Ther; 2016 Apr; 18():90. PubMed ID: 27091114 [TBL] [Abstract][Full Text] [Related]
7. Distribution and presumed proliferation of macrophages in inflammatory diseases of the ocular adnexae. Herwig MC; Holz FG; Loeffler KU Curr Eye Res; 2015 May; 40(6):604-10. PubMed ID: 25111002 [TBL] [Abstract][Full Text] [Related]
8. The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer. Edin S; Wikberg ML; Dahlin AM; Rutegård J; Öberg Å; Oldenborg PA; Palmqvist R PLoS One; 2012; 7(10):e47045. PubMed ID: 23077543 [TBL] [Abstract][Full Text] [Related]
9. Significance of CD163-Positive Macrophages in Proliferative Glomerulonephritis. Li J; Liu CH; Xu DL; Gao B Am J Med Sci; 2015 Nov; 350(5):387-92. PubMed ID: 26379042 [TBL] [Abstract][Full Text] [Related]
10. Palisaded neutrophilic and granulomatous dermatitis associated with systemic lupus erythematosus: possible involvement of CD163 Terai S; Ueda-Hayakawa I; Nguyen CTH; Ly NTM; Yamazaki F; Kambe N; Son Y; Okamoto H Lupus; 2018 Dec; 27(14):2220-2227. PubMed ID: 30376790 [TBL] [Abstract][Full Text] [Related]
11. M2 macrophages and inflammatory cells in oral lesions of chronic paracoccidioidomycosis. de Carli ML; Miyazawa M; Nonogaki S; Shirata NK; Oliveira DT; Pereira AA; Hanemann JA J Oral Pathol Med; 2016 Feb; 45(2):141-7. PubMed ID: 26041558 [TBL] [Abstract][Full Text] [Related]
12. Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma. Sugaya M; Miyagaki T; Ohmatsu H; Suga H; Kai H; Kamata M; Fujita H; Asano Y; Tada Y; Kadono T; Okochi H; Sato S J Dermatol Sci; 2012 Oct; 68(1):45-51. PubMed ID: 22884782 [TBL] [Abstract][Full Text] [Related]
13. Macrophage-specific nanotechnology-driven CD163 overexpression in human macrophages results in an M2 phenotype under inflammatory conditions. Alvarado-Vazquez PA; Bernal L; Paige CA; Grosick RL; Moracho Vilrriales C; Ferreira DW; Ulecia-Morón C; Romero-Sandoval EA Immunobiology; 2017 Aug; 222(8-9):900-912. PubMed ID: 28545809 [TBL] [Abstract][Full Text] [Related]
14. The ratio of CD163-positive macrophages to Iba1-positive macrophages is low in the intima in the early stage of cutaneous arteritis. Kobayashi M; Matsumoto Y; Satomi H; Tateishi A; Ohya M; Ito I; Kanno H Immunol Res; 2020 Jun; 68(3):152-160. PubMed ID: 32578130 [TBL] [Abstract][Full Text] [Related]
15. CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers. Pelekanou V; Villarroel-Espindola F; Schalper KA; Pusztai L; Rimm DL Breast Cancer Res; 2018 Dec; 20(1):154. PubMed ID: 30558648 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease. Enomoto Y; Suzuki Y; Hozumi H; Mori K; Kono M; Karayama M; Furuhashi K; Fujisawa T; Enomoto N; Nakamura Y; Inui N; Suzuki D; Ogawa N; Nakashima R; Mimori T; Iwashita T; Suda T Arthritis Res Ther; 2017 Jan; 19(1):9. PubMed ID: 28103926 [TBL] [Abstract][Full Text] [Related]
17. Evidence for M2 macrophages in granulomas from pulmonary sarcoidosis: A new aspect of macrophage heterogeneity. Shamaei M; Mortaz E; Pourabdollah M; Garssen J; Tabarsi P; Velayati A; Adcock IM Hum Immunol; 2018 Jan; 79(1):63-69. PubMed ID: 29107084 [TBL] [Abstract][Full Text] [Related]
18. Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis. Higashi-Kuwata N; Jinnin M; Makino T; Fukushima S; Inoue Y; Muchemwa FC; Yonemura Y; Komohara Y; Takeya M; Mitsuya H; Ihn H Arthritis Res Ther; 2010; 12(4):R128. PubMed ID: 20602758 [TBL] [Abstract][Full Text] [Related]
19. Association of steroid use with complicated sigmoid diverticulitis: potential role of activated CD68+/CD163+ macrophages. von Rahden BH; Kircher S; Thiery S; Landmann D; Jurowich CF; Germer CT; Grimm M Langenbecks Arch Surg; 2011 Aug; 396(6):759-68. PubMed ID: 21553154 [TBL] [Abstract][Full Text] [Related]
20. Macrophages subpopulations in chronic periapical lesions according to clinical and morphological aspects. França GM; Carmo AFD; Costa Neto H; Andrade ALDL; Lima KC; Galvão HC Braz Oral Res; 2019 May; 33():e047. PubMed ID: 31141038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]